No Data
No Data
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
BofA Securities Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating
BofA Securities analyst Jason Gerberry maintains $Amphastar Pharmaceuticals(AMPH.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 44.4% and a total average
Bank of America Securities Reaffirms Their Hold Rating on Amphastar Pharmaceuticals (AMPH)
Here's Why Amphastar Pharmaceuticals (NASDAQ:AMPH) Can Manage Its Debt Responsibly
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only n
Insider Sale: CFO, EVP & Treasurer William Peters Sells Shares of Amphastar Pharmaceuticals ...
Amphastar Pharmaceuticals(AMPH.US) Officer Sells US$147.17K in Common Stock
$Amphastar Pharmaceuticals(AMPH.US)$ Officer PETERS WILLIAM J sold 3,596 shares of common stock on Jun 27, 2024 at an average price of $40.9258 for a total value of $147.17K.Source: Announcement What